AG-ANASTROZOLE

Aperçu du produit

About AG-ANASTROZOLE

AG-ANASTROZOLE is a medication containing the active ingredient Anastrozole, used in the treatment of hormone receptor-positive breast cancer in postmenopausal women with disease progression following tamoxifen therapy. It is also used in the treatment of early breast cancer in postmenopausal women with hormone receptor-positive or hormone receptor unknown tumors.

Key Benefits & Uses

• Treatment of hormone receptor-positive breast cancer in postmenopausal women with disease progression following tamoxifen therapy.
• Treatment of early breast cancer in postmenopausal women with hormone receptor-positive or hormone receptor unknown tumors.
• Reduction of the risk of invasive breast cancer in postmenopausal women with hormone receptor-positive or progesterone receptor-positive breast cancer.

Active Ingredient & Action

Anastrozole is an aromatase inhibitor that works by blocking the enzyme aromatase, which is responsible for converting androgens to estrogens. By inhibiting this enzyme, Anastrozole reduces the levels of estrogen in the body, which can help slow or stop the growth of hormone receptor-positive breast cancer cells.

Important Notes

AG-ANASTROZOLE should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of side effects. Patients with a history of liver disease or who are taking other medications that may interact with Anastrozole should consult their doctor before starting treatment.